Inventor
KESTELEYN BART RUDOLF ROMANIE
BE36 patents
⚠️ This page may combine multiple inventors who share the name “KESTELEYN BART RUDOLF ROMANIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICALS INC
20 patentsUS10029984B2Jul 24, 2018
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC21 citations94
US9944598B2Apr 17, 2018
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC21 citations94
US10206902B2Feb 19, 2019
Mono- or di-substituted indoles as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC14 citations85
US11827602B2Nov 28, 2023
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC2 citations73
US10919854B2Feb 16, 2021
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC3 citations73
US10696632B2Jun 30, 2020
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC3 citations73
US11180450B2Nov 23, 2021
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC2 citations72
US10689340B2Jun 23, 2020
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC4 citations72
US12172959B2Dec 24, 2024
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations62
US11083707B2Aug 10, 2021
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations62
US10913716B2Feb 9, 2021
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations62
US11795149B2Oct 24, 2023
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations61
US11407715B2Aug 9, 2022
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations61
US11702387B2Jul 18, 2023
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations59
US11053196B2Jul 6, 2021
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations59
US10786484B2Sep 29, 2020
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations52
US10765662B2Sep 8, 2020
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations52
US11179368B2Nov 23, 2021
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations51
US10646469B2May 12, 2020
Substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations51
US10730884B2Aug 4, 2020
Substituted indole compound derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations38
TIBOTEC PHARM LTD
7 patentsUS7126015B2Oct 24, 2006
Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol
TIBOTEC PHARM LTD5 citations60
US7595408B2Sep 29, 2009
Methods for the preparation of (3R,3aS,6aR) hexahydro-furo[2,3-b]furan-3-ol
TIBOTEC PHARM LTD2 citations52
US7615639B2Nov 10, 2009
1-pyridyl-benzofuro[3,2-b]pyridin-2(1H)-ones
TIBOTEC PHARM LTD1 citations47
US7608726B2Oct 27, 2009
Substituted indolepyridinium as anti-infective compounds
TIBOTEC PHARM LTD1 citations41
US7994187B2Aug 9, 2011
HIV inhibiting 3,4-dihydro-imidazo[4,5-B]pyridin-5-ones
TIBOTEC PHARM LTD0 citations40
US7622581B2Nov 24, 2009
6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents
TIBOTEC PHARM LTD0 citations38
US7514427B2Apr 7, 2009
1,5,6,-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-inflective agents
TIBOTEC PHARM LTD0 citations34
JANSSEN SCIENCES IRELAND UC
4 patentsUS10071961B2Sep 11, 2018
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
JANSSEN SCIENCES IRELAND UC33 citations93
US9567299B2Feb 14, 2017
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
JANSSEN SCIENCES IRELAND UC21 citations93
US10450270B2Oct 22, 2019
Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
JANSSEN SCIENCES IRELAND UC3 citations72
US10377709B2Aug 13, 2019
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
JANSSEN SCIENCES IRELAND UC0 citations51
JANSSEN SCIENCES IRELAND UNLIMITED CO
2 patentsUS11491148B2Nov 8, 2022
Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
JANSSEN SCIENCES IRELAND UNLIMITED CO0 citations47
US11096931B2Aug 24, 2021
Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
JANSSEN SCIENCES IRELAND UNLIMITED CO0 citations43